Linda Neuman
Keine laufenden Positionen mehr
Vermögen: 5 592 $ am 31.05.2024
Profil
Linda Neuman held several positions in the pharmaceutical industry, including Medical Director at Onyx Pharmaceuticals, Senior Medical Director at Puma Biotechnology, and Vice President of Clinical Development at Sunesis Pharmaceuticals and Catalyst Biosciences.
She also served as Chief Medical Officer at Adverum Biotechnologies and Spyre Therapeutics.
Dr. Neuman holds a Doctorate degree from Siu School of Medicine, an undergraduate degree from Southern Illinois University, and an MBA from Indiana Wesleyan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SPYRE THERAPEUTICS, INC
0,00% | 23.02.2023 | 160 ( 0,00% ) | 5 592 $ | 31.05.2024 |
Ehemalige bekannte Positionen von Linda Neuman
| Unternehmen | Position | Ende |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 14.04.2023 |
| CATALYST BIOSCIENCES | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2021 |
| ADVERUM BIOTECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2018 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
| PUMA BIOTECHNOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Linda Neuman
| Indiana Wesleyan University | Masters Business Admin |
| Southern Illinois University | Undergraduate Degree |
| Siu School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
